Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
Sheena Friesen, PhD (she/her), is the attending psychologist for the Child Program on the inpatient Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. She has clinical expertise in disruptive behavior disorders, comprehensive assessment, Dialectical Behavior Therapy, Exposure Therapies, Parent Training, and Trauma-Focused Cognitive Behavioral Therapy.
Dr. Friesen’s research interests broadly focus on advancing knowledge of least restrictive interventions in acute and complex care contexts, trauma-informed care, and interventions designed to address children’s disruptive behavior problems. She has collaborated on and co-led efforts to design and implement a multi-tiered, Modified Positive Behavioral Interventions and Supports (M-PBIS) model of care aimed at increasing positive behavior interventions, reducing restraint and PRN use, and ameliorating racial gaps in care delivery.
Dr. Friesen received her Ph.D. in School Psychology from the University of Washington in Seattle, WA. She completed her pre-doctoral internship training at Johns Hopkins School of Medicine and Kennedy Krieger Institute and went on to complete her postdoctoral fellowship in acute care and clinical psychology at Seattle Children’s Hospital.
My clinical and research interests center around behavioral and psychological symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits.
Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.
Dr. Connor Gallik, PhD, is the attending psychologist for the Adolescent Program on the Psychiatry and Behavioral Medicine Unit at Seattle Children’s Hospital and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at University of Washington.
Prior to joining the staff and faculty at Seattle Children’s/UW, Dr. Gallik completed his graduate education at the University of Connecticut with an emphasis in child and adolescent clinical psychology. He completed his clinical internship at Pacific University’s Psychology and Comprehensive Health Clinic and went on to complete a postdoctoral fellowship in clinical psychology at Seattle Children’s Hospital with an emphasis in DBT and inpatient care.
His research focuses on understanding factors related to the mental health and wellbeing of transgender and gender diverse (TGD) TGD youth and evidence-based practice on inpatient units. Clinically, he is interested in working with children, adolescents, and their families, with a focus on TGD youth. Dr. Gallik also provides training in TGD affirming care for mental health and medical professionals and speaks to community audiences about supporting transgender youth.
I am a trained Behavioral Psychologist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. I received my MD from the University of Arkansas for Medical Sciences, and completed my General Psychiatry Residency at the same institution. I completed a fellowship in Consultation-Liaison Psychiatry (formerly Psychosomatic Medicine) at the University of Washington. I have academic interests in the intersection of medicine and psychiatry, LGBTQ mental health and wellbeing, and medical education. I currently see patients at Harborview Medical Center’s Madison HIV Clinic and Fred Hutch Cancer Center.
I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. I received my MD, MPH from the University of Nebraska Medical Center and completed my adult residency at the University of Washington where I was chief resident. I then went on to complete a fellowship in Consultation-Liaison Psychiatry at the University of Washington. I am currently on faculty at Harborview Medical Center on the inpatient psychiatry unit and inpatient psychiatry consult service. I have a longstanding interest in the intersection between medicine and psychiatry and in working with people who suffer from serious mental illness and treatment-resistant conditions. I have clinical interests in ECT, psychopharmacology, co-morbid medical conditions, and adjunctive psychotherapies. I value caring for the whole person through thorough and accurate diagnosis, treating co-morbid medical conditions, and minimizing medications when possible. I have teaching interests in reducing stigma surrounding serious mental illness and educating residents and medical students about psychiatric care.
